SSKN OTC
STRATA Skin Sciences, Inc.
1W: +0.0%
1M: +0.0%
3M: -96.2%
YTD: -99.6%
1Y: -99.7%
3Y: -99.9%
5Y: -100.0%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$31M
-8.5% ▼
5Y CAGR: +5.9%
Gross Profit
$18M
-6.3% ▼
5Y CAGR: +4.8%
Operating Income
-$6M
+37.0% ▲
Net Income
-$6M
+37.9% ▲
EPS (Diluted)
$-1.35
-419.2% ▼
EBITDA
-$1M
+51.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $30M | $36M | $33M | $34M | $31M |
| YoY Growth | +29.8% | +20.6% | -7.8% | +0.6% | -8.5% |
| Cost of Revenue | $10M | $14M | $15M | $14M | $13M |
| Gross Profit | $20M | $22M | $18M | $19M | $18M |
| Gross Margin | 66.2% | 60.2% | 55.3% | 56.9% | 58.3% |
| R&D Expenses | $1M | $1M | $1M | $883K | $421K |
| SG&A Expenses | $23M | $25M | $23M | $24M | $23M |
| Operating Expenses | $24M | $26M | $27M | $28M | $24M |
| Operating Income | -$4M | -$5M | -$9M | -$9M | -$6M |
| Operating Margin | -14.7% | -12.9% | -25.8% | -27.6% | -19.0% |
| Interest Expense | $314K | $926K | $2M | $2M | $2M |
| Income Before Tax | -$3M | -$5M | -$11M | -$10M | -$6M |
| Tax Expense | $34K | $63K | -$92K | -$170K | $12K |
| Net Income | -$3M | -$6M | -$11M | -$10M | -$6M |
| Net Margin | -9.0% | -15.3% | -32.5% | -30.1% | -20.4% |
| EPS (Diluted) | $-0.08 | $-0.16 | $-0.31 | $-0.26 | $-1.35 |
| EBITDA | $2M | $1M | -$3M | -$3M | -$1M |
| Shares Outstanding | 34M | 35M | 35M | 38M | 47M |